Oppenheimer & Co. Inc. reduced its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 7.3% in the fourth quarter, Holdings Channel reports. The fund owned 192,330 shares of the biopharmaceutical company’s stock after selling 15,254 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Bristol-Myers Squibb were worth $9,868,000 as of […]